-
Je něco špatně v tomto záznamu ?
Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity
Y. Cai, AM. Makarova, J. Wengel, KA. Howard,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
29800498
DOI
10.1002/jgm.3025
Knihovny.cz E-zdroje
- MeSH
- albuminy metabolismus MeSH
- antisense oligonukleotidy chemie genetika metabolismus MeSH
- lidé MeSH
- lipoylace MeSH
- molekulární struktura MeSH
- nádorové buněčné linie MeSH
- receptor erbB-3 genetika MeSH
- techniky in vitro MeSH
- transfekce MeSH
- umlčování genů * MeSH
- vazba proteinů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Antisense gapmer oligonucleotide drugs require delivery and biodistribution enabling technologies to increase in vivo efficacy. An attractive approach is their binding and consequent transport by the endogenous human serum albumin pool as mediated by fatty acid incorporation into the gapmer design. METHODS: The present study investigated the effect of palmitoyl modification and position on albumin-binding, cellular uptake and in vitro gene silencing of gapmers with either a phosphorothioate (PS) or phosphodiester (PO) backbone. RESULTS: Two palmitoyls positioned exclusively at the 5' end, or a single palmitoyl at both the 3' and 5' positions, showed similar binding to human serum albumin as demonstrated by a gel-shift assay. Decreased cellular uptake determined by flow cytometry (27% compared to nonpalmitoyl gapmers) was observed for palmitoylated Cy5.5 labelled gapmers. However, HER3 (human epidermal growth factor receptor 3) gene silencing was exhibited by the palmitoylated gapmers with transfection agent in PC-3 and Caco-2 cells (68% and 62%, respectively), which was comparable to nonpalmitoyl gapmers (68% and 82%, respectively). Importantly, PO gapmers with a single palmitoyl positioned at both the 3' and 5' positions showed high silencing efficiencies (68% and 66% in PC-3 and Caco-2 cells, respectively) similar to those of PS nonpalmitoylated gapmers (67% and 66% in PC-3 and Caco-2 cells, respectively) in the absence of a transfection agent. CONCLUSIONS: The present study defines phosphodiester gapmer design criteria exhibiting high gene silencing activity and albumin binding that may be utilized with potentially less in vivo toxicity that can be associated with phosphorothioate gapmer designs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045443
- 003
- CZ-PrNML
- 005
- 20200120085707.0
- 007
- ta
- 008
- 200109s2018 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jgm.3025 $2 doi
- 035 __
- $a (PubMed)29800498
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Cai, Yunpeng $u The Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.
- 245 10
- $a Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity / $c Y. Cai, AM. Makarova, J. Wengel, KA. Howard,
- 520 9_
- $a BACKGROUND: Antisense gapmer oligonucleotide drugs require delivery and biodistribution enabling technologies to increase in vivo efficacy. An attractive approach is their binding and consequent transport by the endogenous human serum albumin pool as mediated by fatty acid incorporation into the gapmer design. METHODS: The present study investigated the effect of palmitoyl modification and position on albumin-binding, cellular uptake and in vitro gene silencing of gapmers with either a phosphorothioate (PS) or phosphodiester (PO) backbone. RESULTS: Two palmitoyls positioned exclusively at the 5' end, or a single palmitoyl at both the 3' and 5' positions, showed similar binding to human serum albumin as demonstrated by a gel-shift assay. Decreased cellular uptake determined by flow cytometry (27% compared to nonpalmitoyl gapmers) was observed for palmitoylated Cy5.5 labelled gapmers. However, HER3 (human epidermal growth factor receptor 3) gene silencing was exhibited by the palmitoylated gapmers with transfection agent in PC-3 and Caco-2 cells (68% and 62%, respectively), which was comparable to nonpalmitoyl gapmers (68% and 82%, respectively). Importantly, PO gapmers with a single palmitoyl positioned at both the 3' and 5' positions showed high silencing efficiencies (68% and 66% in PC-3 and Caco-2 cells, respectively) similar to those of PS nonpalmitoylated gapmers (67% and 66% in PC-3 and Caco-2 cells, respectively) in the absence of a transfection agent. CONCLUSIONS: The present study defines phosphodiester gapmer design criteria exhibiting high gene silencing activity and albumin binding that may be utilized with potentially less in vivo toxicity that can be associated with phosphorothioate gapmer designs.
- 650 _2
- $a albuminy $x metabolismus $7 D000418
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a umlčování genů $7 D020868
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a lipoylace $7 D054878
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a antisense oligonukleotidy $x chemie $x genetika $x metabolismus $7 D016376
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a receptor erbB-3 $x genetika $7 D020893
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Makarova, Anna-Marie $u Faculty of Science, Charles University in Prague, Czech Republic.
- 700 1_
- $a Wengel, Jesper $u Nucleic Acid Center, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark.
- 700 1_
- $a Howard, Kenneth A $u The Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.
- 773 0_
- $w MED00008737 $t The journal of gene medicine $x 1521-2254 $g Roč. 20, č. 7-8 (2018), s. e3025
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29800498 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200120090044 $b ABA008
- 999 __
- $a ok $b bmc $g 1483712 $s 1084116
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 20 $c 7-8 $d e3025 $e 20180625 $i 1521-2254 $m The Journal of gene medicine $n J Gene Med $x MED00008737
- LZP __
- $a Pubmed-20200109